IAN
FLETCHER

ECONOMIST & AUTHOR

Economist Ian Fletcher is one of America’s foremost experts on the problems of free trade. He is the author of Free Trade Doesn’t Work and the coauthor of  The Conservative Case Against Free Trade and Industrial Policy for the United States.

 


 

He has been senior economist at the Coalition, a research fellow at the US Business and Industry Council, an economist in private practice, and an IT consultant. He was educated at Columbia University and the University of Chicago. He lives in San Francisco.

 

CPA Speakers Bureau Member: Ian Fletcher is available to speak to the topics of:

  1. Trade and Free Trade Agreements
  2. Why free trade is bad
  3. Globalization/globalism
  4. What’s wrong with economics as a discipline.

 

Ian Fletcher

MORE FROM IAN FLETCHER

Playlist

13 Videos

THE LATEST FROM CPA

Blaming Tariffs Won’t Fix the Cost-of-Living Crisis

Blaming Tariffs Won’t Fix the Cost-of-Living Crisis

Since September, there have been at least six surveys showing a general disagreement with the Trump administration’s tariff policy. The main takeaways are that the public is against the recent, new tariff impositions on Canada – and that tariffs are contributing to the rising cost of living. That these new polls are coming out during an election cycle is no surprise. But regardless of the timing, tariffs and their impacts on the rising cost of living could use some better explaining.

READ MORE ➔
After U.S. Restrictions, Chinese Connected Vehicles Face Growing Scrutiny in Europe

After U.S. Restrictions, Chinese Connected Vehicles Face Growing Scrutiny in Europe

In one month, between mid-September and mid-October, Chinese technology attached to new cars – mostly EVs, but not all – were called out in two European countries for essentially being data vacuums for China. In some cases, the data is collected for the companies to understand how the driver uses their product, and to make adjustments over time. But in other cases, they were used as on-board recording devices.

READ MORE ➔
FDA Warns Online Sellers Over Unapproved Semaglutide Injections Marketed Under Indian Drugmakers' Brands

FDA Warns Online Sellers Over Unapproved Semaglutide Injections Marketed Under Indian Drugmakers’ Brands

As Capitol Hill debates what the future of the U.S. generic drugs industry will look like, another alarm bell has rung at the Food and Drug Administration (FDA). This time, imported semaglutide generics – similar to Ozempic – sold by a company called the Cheap Medicine Shop were issued an FDA Warning Letter for marketing a drug that had not been approved for sale in the U.S.

READ MORE ➔